Targeting Super-Enhancer-Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor.
Zhang J, Liu W, Zou C, Zhao Z, Lai Y, Shi Z, Xie X, Huang G, Wang Y, Zhang X, Fan Z, Su Q, Yin J, Shen J.
Zhang J, et al. Among authors: fan z.
Clin Cancer Res. 2020 Jun 1;26(11):2681-2692. doi: 10.1158/1078-0432.CCR-19-1418. Epub 2020 Jan 14.
Clin Cancer Res. 2020.
PMID: 31937612